AMR

World leaders at UNGA commit to a 10% reduction in AMR deaths by 2030, driving a global push for sustainable, multi-sector…

Anthony McDonnell, policy fellow at the Center for Global Development's global health policy team and lead author of a recent…

This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…

Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by…

He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives and to favourably…

According to Courtney Soulsby, AMR continues to threaten global population health, particularly across India. An opportunity to…

In addition to the FDA approval, EXBLIFEP has also been submitted for marketing approval in the EU and received a positive opinion…

Plazomicin is a new Intravenous (IV) aminoglycoside indicated for the treatment of complicated urinary tract infections (cUTI)…

Aurangabad, India site is the country’s first pharma facility, and first in Viatris’ network, to meet new British Standards…

Over-the-counter accessibility and limited awareness compound the problem. India's challenges, including resource scarcity and…